Immune spleen cells attenuate the inflammatory profile of the mesenteric perivascular adipose tissue in obese mice.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
27 05 2021
Historique:
received: 18 01 2021
accepted: 11 05 2021
entrez: 28 5 2021
pubmed: 29 5 2021
medline: 3 11 2021
Statut: epublish

Résumé

The perivascular adipose tissue (PVAT) differs from other fat depots and exerts a paracrine action on the vasculature. The spleen has an important role in the immune response, and it was observed to have either a protective role or a contribution to obesity-related diseases. However, the relation between spleen and PVAT is elusive in obesity. We investigated the role of spleen in the inflammatory profile of the mesenteric PVAT (mPVAT) from mice fed a high-fat diet (HFD) for 16 weeks. Male C57Bl/6 mice were sham-operated or splenectomized (SPX) and fed a HFD for 16 weeks. mPVAT morphology was evaluated by hematoxylin and eosin staining, infiltrated immune cells were evaluated by flow cytometry, inflammatory cytokines were evaluated by ELISA and the splenic cell chemotaxis mediated by mPVAT was evaluated using a transwell assay. In SPX mice, HFD induced adipocyte hypertrophy and increased immune cell infiltration and proinflammatory cytokine levels in mPVAT. However, none of these effects were observed in mPVAT from sham-operated mice. Spleen from HFD fed mice presented reduced total leukocytes and increased inflammatory markers when compared to the spleen from control mice. Chemotaxis of spleen cells mediated by mPVAT of HFD fed mice was reduced in relation to standard diet fed mice. The spleen protects mPVAT against the effects of 16-week HFD. This information was missing, and it is important because PVAT is different from other fat depots and data cannot be extrapolated from any type of adipose tissue to PVAT.

Identifiants

pubmed: 34045574
doi: 10.1038/s41598-021-90600-0
pii: 10.1038/s41598-021-90600-0
pmc: PMC8160359
doi:

Substances chimiques

Cytokines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11153

Références

Front Immunol. 2018 Jun 05;9:1286
pubmed: 29922297
Metabolism. 2015 Sep;64(9):1122-33
pubmed: 26026366
Nat Med. 2009 Aug;15(8):914-20
pubmed: 19633658
PLoS Biol. 2010 Jun 29;8(6):e1000412
pubmed: 20613859
PLoS One. 2011;6(8):e23164
pubmed: 21829713
PLoS One. 2014 Mar 04;9(3):e90639
pubmed: 24595332
J Neurochem. 2012 Mar;120(5):752-64
pubmed: 22146087
Nat Rev Immunol. 2005 Aug;5(8):606-16
pubmed: 16056254
J Biol Chem. 2003 Dec 12;278(50):50810-7
pubmed: 14522956
Eur J Immunol. 2013 Oct;43(10):2659-70
pubmed: 23813052
Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1458-64
pubmed: 19608970
J Pediatr Surg. 2011 Sep;46(9):1706-10
pubmed: 21929978
Circ Res. 2009 Feb 27;104(4):541-9
pubmed: 19122178
Cardiovasc Diabetol. 2016 Aug 25;15(1):119
pubmed: 27562094
Eur J Pharmacol. 2002 Apr 12;440(2-3):213-21
pubmed: 12007537
Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2594-9
pubmed: 16195477
Proc Natl Acad Sci U S A. 2012 May 15;109(20):7622-9
pubmed: 22538809
Br J Pharmacol. 2017 Oct;174(20):3425-3442
pubmed: 27761903
Br J Pharmacol. 2017 Oct;174(20):3496-3513
pubmed: 28063251
Cell Metab. 2013 Nov 5;18(5):759-766
pubmed: 24209772
Sci Rep. 2020 Aug 20;10(1):14052
pubmed: 32820201
Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1621-30
pubmed: 24833795
Am J Physiol Endocrinol Metab. 2007 Oct;293(4):E1118-28
pubmed: 17666485
J Immunol Res. 2020 Feb 11;2020:5948256
pubmed: 32104715
Diabetes. 2012 Feb;61(2):346-54
pubmed: 22190646
Diabetes. 2012 Aug;61(8):1994-2003
pubmed: 22648387
Sci Rep. 2018 Feb 14;8(1):3023
pubmed: 29445164
Arterioscler Thromb Vasc Biol. 2016 Jul;36(7):1377-85
pubmed: 27174097
Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):E4638-47
pubmed: 25313053
Exp Biol Med (Maywood). 2012 Apr;237(4):461-70
pubmed: 22490513
Cell. 2014 Jun 5;157(6):1339-1352
pubmed: 24906151
Nucleic Acids Res. 2001 May 1;29(9):e45
pubmed: 11328886
Oncol Lett. 2018 Jun;15(6):8187-8194
pubmed: 29805553
J Biol Chem. 2007 Nov 30;282(48):35279-92
pubmed: 17916553
PLoS Comput Biol. 2009 Mar;5(3):e1000324
pubmed: 19325873
Front Immunol. 2014 Nov 06;5:568
pubmed: 25414706
Immunology. 2015 Jul;145(3):334-46
pubmed: 25827019
J Clin Invest. 2011 Jun;121(6):2111-7
pubmed: 21633179
Obesity (Silver Spring). 2010 Oct;18(10):1902-5
pubmed: 20057372

Auteurs

Renée de Nazaré Oliveira da Silva (RNO)

Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.

Rosangela Aparecida Santos-Eichler (RA)

Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.

Carolina Dias (C)

Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.

Stephen Fernandes Rodrigues (SF)

Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.

Dominik S Skiba (DS)

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
Department of Experimental Genomics, Institute of Genetics and Animal Biotechnology Polish Academy of Sciences, Jastrzebiec, Poland.

Richardt Gama Landgraf (RG)

Department of Pharmaceutical Sciences, Federal University of São Paulo, Diadema, Brazil.

Maria Helena Catelli de Carvalho (MHC)

Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.

Tomasz Guzik (T)

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

Ricardo Ambrósio Fock (RA)

Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.

Eliana Hiromi Akamine (EH)

Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil. eliakamine@usp.br.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH